321 related articles for article (PubMed ID: 18978796)
1. 5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma.
Poeck H; Besch R; Maihoefer C; Renn M; Tormo D; Morskaya SS; Kirschnek S; Gaffal E; Landsberg J; Hellmuth J; Schmidt A; Anz D; Bscheider M; Schwerd T; Berking C; Bourquin C; Kalinke U; Kremmer E; Kato H; Akira S; Meyers R; Häcker G; Neuenhahn M; Busch D; Ruland J; Rothenfusser S; Prinz M; Hornung V; Endres S; Tüting T; Hartmann G
Nat Med; 2008 Nov; 14(11):1256-63. PubMed ID: 18978796
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.
Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M
Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
Meng G; Xia M; Xu C; Yuan D; Schnurr M; Wei J
Int J Cancer; 2014 Apr; 134(8):1958-71. PubMed ID: 23921958
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of duplex RNA harboring 5'-terminal triphosphate on gene silencing and RIG-I mediated innate immune response.
Baek SE; Kim H; Kim KB; Yoon S; Choe J; Suh W; Jeong YJ; Cho YH; Kim DE
Biochem Biophys Res Commun; 2015 Jan; 456(2):591-7. PubMed ID: 25490387
[TBL] [Abstract][Full Text] [Related]
5. 5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation.
Lin L; Liu Q; Berube N; Detmer S; Zhou Y
J Virol; 2012 Oct; 86(19):10359-69. PubMed ID: 22787226
[TBL] [Abstract][Full Text] [Related]
6. 5'-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro.
Wang K; Chen X; Yan F; Xing Y; Yang X; Tu J; Chen Z
J Immunother; 2013 Jun; 36(5):294-304. PubMed ID: 23719240
[TBL] [Abstract][Full Text] [Related]
7. Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.
Glas M; Coch C; Trageser D; Dassler J; Simon M; Koch P; Mertens J; Quandel T; Gorris R; Reinartz R; Wieland A; Von Lehe M; Pusch A; Roy K; Schlee M; Neumann H; Fimmers R; Herrlinger U; Brüstle O; Hartmann G; Besch R; Scheffler B
Stem Cells; 2013 Jun; 31(6):1064-74. PubMed ID: 23390110
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs.
Yuan D; Xia M; Meng G; Xu C; Song Y; Wei J
Oncotarget; 2015 Oct; 6(30):29664-74. PubMed ID: 26336994
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.
Besch R; Poeck H; Hohenauer T; Senft D; Häcker G; Berking C; Hornung V; Endres S; Ruzicka T; Rothenfusser S; Hartmann G
J Clin Invest; 2009 Aug; 119(8):2399-411. PubMed ID: 19620789
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting bcl-2 sensitizes malignant melanoma.
Wacheck V; Losert D; Günsberg P; Vornlocher HP; Hadwiger P; Geick A; Pehamberger H; Müller M; Jansen B
Oligonucleotides; 2003; 13(5):393-400. PubMed ID: 15000830
[TBL] [Abstract][Full Text] [Related]
11. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.
Pichlmair A; Schulz O; Tan CP; Näslund TI; Liljeström P; Weber F; Reis e Sousa C
Science; 2006 Nov; 314(5801):997-1001. PubMed ID: 17038589
[TBL] [Abstract][Full Text] [Related]
12. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
Han Q; Hou Z; Yin C; Zhang C; Zhang J
Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
[TBL] [Abstract][Full Text] [Related]
13. An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
Castiello L; Zevini A; Vulpis E; Muscolini M; Ferrari M; Palermo E; Peruzzi G; Krapp C; Jakobsen M; Olagnier D; Zingoni A; Santoni A; Hiscott J
Cancer Immunol Immunother; 2019 Sep; 68(9):1479-1492. PubMed ID: 31463653
[TBL] [Abstract][Full Text] [Related]
14. Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production.
He S; Zhao J; Song S; He X; Minassian A; Zhou Y; Zhang J; Brulois K; Wang Y; Cabo J; Zandi E; Liang C; Jung JU; Zhang X; Feng P
Mol Cell; 2015 Apr; 58(1):134-46. PubMed ID: 25752576
[TBL] [Abstract][Full Text] [Related]
15. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling.
Peng D; Chen L; Sun Y; Sun L; Yin Q; Deng S; Niu L; Lou F; Wang Z; Xu Z; Wang C; Fan L; Wang H; Wang H
Biomed Pharmacother; 2020 May; 125():109984. PubMed ID: 32066042
[TBL] [Abstract][Full Text] [Related]
16. Approaching the RNA ligand for RIG-I?
Schlee M; Hartmann E; Coch C; Wimmenauer V; Janke M; Barchet W; Hartmann G
Immunol Rev; 2009 Jan; 227(1):66-74. PubMed ID: 19120476
[TBL] [Abstract][Full Text] [Related]
17. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
Han Q; Zhang C; Zhang J; Tian Z
Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.
Benimetskaya L; Ayyanar K; Kornblum N; Castanotto D; Rossi J; Wu S; Lai J; Brown BD; Popova N; Miller P; McMicken H; Chen Y; Stein CA
Clin Cancer Res; 2006 Aug; 12(16):4940-8. PubMed ID: 16914583
[TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
[TBL] [Abstract][Full Text] [Related]
20. Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells.
Kübler K; Gehrke N; Riemann S; Böhnert V; Zillinger T; Hartmann E; Pölcher M; Rudlowski C; Kuhn W; Hartmann G; Barchet W
Cancer Res; 2010 Jul; 70(13):5293-304. PubMed ID: 20551064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
